Lisata Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 254.18 K | $597.33 K | 36.39% | 2.95% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 216.85 K | $509.61 K | -23.82% | 2.52% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 102.72 K | $241.40 K | 1.38% | 1.19% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 60.53 K | $142.28 K | 8.29% | 0.70% |
BLACKROCK, INC. | 05/02/2025 | 54.86 K | $128.91 K | -2.06% | 0.64% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 25.22 K | $59.27 K | -0.02% | 0.29% |
STATE STREET CORP | 05/15/2025 | 14.35 K | $33.72 K | 0.00% | 0.17% |
COOK WEALTH MANAGEMENT GROUP LLC | 05/15/2025 | 12.18 K | $29.34 K | 0.00% | 0.14% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 10.41 K | $24.47 K | 0.03% | 0.12% |
NORTHERN TRUST CORP | 05/13/2025 | 10.27 K | $24.13 K | 100.00% | 0.12% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 10.04 K | $23.60 K | 0.00% | 0.12% |
ROYAL BANK OF CANADA | 05/15/2025 | 5.91 K | $14.00 K | 100.00% | 0.07% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.21 K | $5.19 K | 15.25% | 0.03% |
FOUNDERS CAPITAL MANAGEMENT | 04/08/2025 | 2.00 K | $4.70 K | 0.00% | 0.02% |
MORGAN STANLEY | 05/15/2025 | 1.47 K | $3.45 K | 0.00% | 0.02% |
05/02/2025 | 140 | $329 | -74.07% | 0.00% | |
05/15/2025 | 20 | $43 | 100.00% | 0.00% | |
JPMORGAN CHASE & CO | 05/12/2025 | 13 | $31 | -13.33% | 0.00% |
CHEVIOT VALUE MANAGEMENT, LLC | 05/09/2025 | 3 | $7 | 100.00% | 0.00% |
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 04/24/2025 | 2 | $5 | 100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 1 | $2 | 0.00% | 0.00% |
UBS GROUP AG | 05/13/2025 | 1 | $2 | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Lisata Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Lisata Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 254,182
BML Capital Management, LLC: 216,853
RENAISSANCE TECHNOLOGIES LLC: 102,722
GEODE CAPITAL MANAGEMENT, LLC: 60,529
BlackRock, Inc.: 54,857
DIMENSIONAL FUND ADVISORS LP: 25,222
9.11% of Lisata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 837.23 K shares in the last 24 months. This purchase volume represents approximately $2.14 M in transactions.